Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2293]

Denis Horgan explains the importance of actively engaging policy makers in...

Denis Horgan - Executive Director, European Alliance for Personalised Medicine

Denis Horgan explains the importance of actively engaging policy makers in PIONEER ( Denis Horgan - Executive Director, European Alliance for Personalised Medicine )

Prof James N’Dow, Academic lead for PIONEER, reflects on the first twelve...

Prof James N’Dow - Chairperson, European Association of Urology Guidelines...

Prof James N’Dow, Academic lead for PIONEER, reflects on the first twelve months of the project ( Prof James N’Dow - Chairperson, European Association of Urology Guidelines Office )

Louise Fullwood explains the legal and ethical issues around data privacy...

Louise Fullwood - Legal Director, Pinsent Masons

Louise Fullwood explains the legal and ethical issues around data privacy within PIONEER ( Louise Fullwood - Legal Director, Pinsent Masons )

Prof Maria Ribal discusses how effective dissemination is key to PIONEER’s long...

Prof Maria Ribal - Chairperson, EAU Guidelines Dissemination Committee

Prof Maria Ribal discusses how effective dissemination is key to PIONEER’s long-term success ( Prof Maria Ribal - Chairperson, EAU Guidelines Dissemination Committee )

Dr Mieke Van Hemelrijck explains the importance of define core outcome sets for...

Dr Mieke Van Hemelrijck - Kings College London, Translational Oncology &...

Dr Mieke Van Hemelrijck explains the importance of define core outcome sets for prostate cancer ( Dr Mieke Van Hemelrijck - Kings College London, Translational Oncology & Urology Research (TOUR) )

PIONEER research associates from both academic and industry discuss their...

Claudio Sartini, Katharina Beyer, Eleni Vradi, Dr Lisa Morris, Dr Kostas...

PIONEER research associates from both academic and industry discuss their experience of working together ( Claudio Sartini, Katharina Beyer, Eleni Vradi, Dr Lisa Morris, Dr Kostas Dimitropoulos, Dr Peter-Paul Willemse )

Dr Thomas Abbott, EFPIA co-lead for PIONEER, discusses data sources and access...

Dr Thomas Abbott - Head, Real World Evidence at Astellas Pharmaceuticals

Dr Thomas Abbott, EFPIA co-lead for PIONEER, discusses data sources and access to data ( Dr Thomas Abbott - Head, Real World Evidence at Astellas Pharmaceuticals )

Dr Zsuzsanna Devecseri, EFPIA co-lead for PIONEER, discusses prostate cancer...

Dr Zsuzsanna Devecseri - Head, Global Oncology Medical, Sanofi

Dr Zsuzsanna Devecseri, EFPIA co-lead for PIONEER, discusses prostate cancer outcomes ( Dr Zsuzsanna Devecseri - Head, Global Oncology Medical, Sanofi )

Second-line and beyond in mCRC: Optimising the benefit and reducing the risk

Prof Mohamed Salem - Georgetown University Hospital, Washington D.C., USA

Second-line and beyond in mCRC: Optimising the benefit and reducing the risk ( Prof Mohamed Salem - Georgetown University Hospital, Washington D.C., USA )

Controversies in the management of prostate cancer

Prof Mach Roach III - University of California, San Francisco, USA

Controversies in the management of prostate cancer ( Prof Mach Roach III - University of California, San Francisco, USA )

Optimum duration of adjuvant treatment of stage III colorectal cancer: 3 versus...

Prof John Marshall - Georgetown University Hospital, Washington D.C., USA

Optimum duration of adjuvant treatment of stage III colorectal cancer: 3 versus 6 months ( Prof John Marshall - Georgetown University Hospital, Washington D.C., USA )

Rectal cancers: Positioning of watchful waiting and minimally invasive...

Prof Henk Wegstapel - Canterbury Christ Church University, Canterbury, UK

Rectal cancers: Positioning of watchful waiting and minimally invasive procedures ( Prof Henk Wegstapel - Canterbury Christ Church University, Canterbury, UK )

More from ecancer